KIM PING LEUNG STONE

Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine GLENVIEW, IL NPI 1649255159

General Payments — all program years on this page

$2,547.62

  • Category: General Payments
  • Program years: PY2018–2020
  • Record count: 148
  • As of (CMS publication): 2026-01-23

Latest program year (PY2020): $751.39 across 42 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2020) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $751.3942

By paying entity

Latest program year (PY2020) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $921.3060
2019 $874.9346
2020 $751.3942

Records — PY2020 (42)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
716726989 Kowa Pharmaceuticals America, Inc. $13.23 05/05/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
718348791 Astellas Pharma US Inc $16.05 10/30/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719252715 Janssen Pharmaceuticals, Inc $17.02 03/10/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719252717 Janssen Pharmaceuticals, Inc $17.00 01/30/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719252719 Janssen Pharmaceuticals, Inc $19.57 11/17/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
720789835 Boehringer Ingelheim Pharmaceuticals, Inc. $24.17 02/14/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
720789839 Boehringer Ingelheim Pharmaceuticals, Inc. $15.69 09/16/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
720789845 Boehringer Ingelheim Pharmaceuticals, Inc. $23.39 07/17/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
721416381 Horizon Therapeutics plc $22.63 10/06/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
721416383 Horizon Therapeutics plc $22.07 11/06/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
721987133 AbbVie Inc. $21.25 08/04/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
721987135 AbbVie Inc. $25.66 10/01/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
721987139 AbbVie Inc. $16.93 10/29/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650601 Allergan, Inc. $13.85 02/12/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650603 Allergan, Inc. $5.80 02/19/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650605 Allergan, Inc. $6.17 03/16/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650607 Allergan, Inc. $9.27 04/07/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650609 Allergan, Inc. $5.58 04/30/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650611 Allergan, Inc. $18.77 05/22/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650613 Allergan, Inc. $17.98 06/05/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650615 Allergan, Inc. $7.01 06/24/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650617 Allergan, Inc. $21.05 07/28/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650619 Allergan, Inc. $16.57 08/26/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650621 Allergan, Inc. $29.02 10/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723650623 Allergan, Inc. $29.02 11/13/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736346351 AstraZeneca Pharmaceuticals LP $19.29 03/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
737220287 Esperion Therapeutics, Inc. $21.86 10/14/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738539353 GlaxoSmithKline, LLC. $19.64 09/14/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738582019 GlaxoSmithKline, LLC. $12.44 07/22/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738739415 GlaxoSmithKline, LLC. $14.40 07/13/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738926453 GlaxoSmithKline, LLC. $17.60 01/23/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
740072525 Amarin Pharma Inc. $20.24 09/30/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
740072527 Amarin Pharma Inc. $22.43 10/16/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
741182411 Amgen Inc. $20.67 05/12/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
741182415 Amgen Inc. $20.65 06/23/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
741182417 Amgen Inc. $18.02 09/09/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744619641 Novo Nordisk Inc $16.21 02/08/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744752745 Novo Nordisk Inc $24.94 06/18/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744843365 Novo Nordisk Inc $15.19 08/14/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744848107 Novo Nordisk Inc $17.63 08/26/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744945057 Novo Nordisk Inc $18.84 10/14/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
745022029 Novo Nordisk Inc $16.59 07/15/2020 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.